The limitations of immunosuppressant therapy in Multiple Sclerosis

J Clin Neurosci. 2000 Nov;7(6):563-4; discussion 564-5. doi: 10.1054/jocn.2000.0790.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Methotrexate / therapeutic use
  • Mitoxantrone / therapeutic use
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / psychology

Substances

  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Mitoxantrone
  • Methotrexate